To Improve Melanoma Outcomes, Focus on Risk Stratification, Not Overdiagnosis

JAMA Dermatol. 2022 May 1;158(5):485-487. doi: 10.1001/jamadermatol.2022.0097.

Authors

Rajan P Kulkarni^{1

2

3

4}, Wesley Y Yu^{1

4}, Sancy A Leachman¹

Affiliations

¹ Department of Dermatology, Oregon Health and Science University, Portland.
² Department of Biomedical Engineering, Oregon Health and Science University, Portland.
³ Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland.
⁴ Operative Care Division, VA Portland Health Care System, Portland, Oregon.

PMID: 35385059
DOI: 10.1001/jamadermatol.2022.0097

No abstract available

Publication types

Comment

MeSH terms

Early Detection of Cancer
Humans
Medical Overuse / prevention & control
Melanoma* / diagnosis
Risk Assessment